Tag: entrepreneurs
-
Trial Shows Antibody Slows Alzheimer’s Cognitive Decline
A clinical trial shows older individuals with early or mild cases of Alzheimer’s disease treated for a year with an engineered human antibody have less decline in mental functions associated with Alzheimer’s disease.
-
Small Molecule Drug Discovery Patent Issued
A company developing small-molecule treatments for biological targets considered difficult to address is receiving a patent for its core drug identification technology.
-
Small Business Award Funding Epilepsy Drug Research
A federal grant is funding a project by Neuroene Therapeutics, a start-up enterprise in South Carolina to develop a new class of drugs to treat epilepsy.
-
Patent Set for Heart Tissue Regeneration Drug
A drug developed by MDI Biological Laboratory that stimulates growth of heart tissue to fix damage from heart attacks is scheduled to receive a U.S. patent.
-
University Spin-Off Developing Sepsis Drug
A spin-off enterprise from University of British Columbia is licensing a cholesterol-lowering drug from drug maker Novartis to develop a treatment for sepsis and other severe infections.
-
Stem Cells, Engineered Protein Reverse Stroke Damage
A combination of stem cells and synthetic human protein was shown in lab mice to repair damaged brain cells a week after an induced stroke.
-
Genome Engineering Streamlines E. Coli DNA
A genetics engineering team developed a technique for modifying the genome of E. coli bacteria to remove redundant DNA components, a step toward designing new organisms.
-
Safer Pain-Killing Drug Candidate Discovered
A research team from the U.S. and Germany identified a chemical molecule with pain-killing properties of opioids, but apparently without the dangerous side effects.
-
Chip Device Simulates Blood Vessels in Clotting
Researchers at a Harvard University bioengineering center developed a plastic chip that simulates critical interactions between tissue lining blood vessels and platelets that affect the flow of blood.
-
FDA Clears Thin, Transparent Wound Dressing Material
The Food and Drug Administration cleared a new type of thin, transparent wound dressing for marketing in the U.S. as a medical device.